Arran Chemical Company

Activities: Ingredients

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  3. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  4. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  5. Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Research & Development

Towards the enzymatic synthesis of oligonucleotides: part II

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, it’s only fair to say that this drug class is becoming big business
Research & Development

Towards the enzymatic synthesis of oligonucleotides: part I

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, it’s only fair to say that this drug class is becoming big business
Training & Education

Arran and AIT collaborate on green chemical production methods

The collaboration will facilitate on a four-year PhD scholarship to deliver greener and more economic alternatives to chemical production methods
Finance

Arran Chemical Company completes stage II of its strategic plan “ADAPT”

Completion of multi-million Euro expansion of manufacturing capacity and deployment of next generation production technologies
Manufacturing

Arran Chemical Company completes first phase of 3 part strategic plan

Irish based Arran Chemical Company has responded to client demand for provision of fine chemicals, pharmaceutical intermediates and advanced building blocks by implementation of its Arran Deploys Advanced Production Technologies (ADAPT) strategy through a multi-million Euro investment and application of its selectAZyme technology
Ingredients

Almac wins prestigious research and development award

Almac Group, the global contract development and manufacturing organisation is delighted to have won the coveted research and development achievement award at this year's Pharma Industry Awards
Subscribe now